Clinical Trials Browser

Breast Neoplasms, Male × alovudine × Breast × Clear all

NCT01928186 2018-05-15

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Phase NA Completed

28 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male